NEXI

0.00010.00%
JT

John Trainer

Consultant

Mr. John Trainer, M.B.A. was Senior Vice President, Chief Operating Officer at Immunocore Holdings plc since 2024 until 2026. He was Chief Financial Officer at NexImmune, Inc. since January 2020 until September 02, 2023. He will continue to stay with company as Consultant. He joined the Company in January 2020. Before joining us, Mr. Trainer served as Vice President and Head of Partnering and Strategy of MedImmune, the biologics-focused R&D unit of AstraZeneca from February 2017 to July 2019. There, he led all in-licensing, out-licensing and collaboration work for MedImmune including such transactions as the spin-out of Viela Bio. Mr. Trainer was also responsible for working with partners such as Johns Hopkins University and the NIH to help develop promising new companies and technologies. Prior to MedImmune, Mr. Trainer served as Vice President, Corporate Development of AstraZeneca from April 2015 to February 2017, as well as the global commercial leader for AstraZeneca’s infection, neuroscience and gastrointestinal therapeutic areas from May 2013 to April 2015 as well as holding a variety of financial, transactional and commercial roles at MedImmune. Mr. Trainer previously served on the boards of directors of several private biotechnology companies, including Corvidia Therapeutics, Inc. Archigen Biotech Limited and Fujifilm Kyowa Kirin Biologics Co. Ltd. Prior to joining AstraZeneca, Mr. Trainer was a strategy consultant at Monitor Group, where he provided strategic planning in healthcare and other industries. Mr. Trainer received his M.B.A. at Harvard Business School and his B.A. from Harvard College.

Positions